botensilimab   Click here for help

GtoPdb Ligand ID: 14590

Synonyms: AGEN-1181 | AGEN1181
Immunopharmacology Ligand
Compound class: Antibody
Comment: Botensilimab (AGEN-11810) is a Fc-enhanced anti-CTLA-4 monoclonal antibody [5]. It is proposed as an immuno-oncology agent for the treatment of poorly immunogenic and treatment refractory cancers [4,8]. Heavy and light chain peptide sequences for botensilimab are claimed in patent US10912831B1 [9], nominally SEQ IDs 25 and 27 respectively, and these are the chains of clone AGEN1884.H3 therein.
Classification Click here for help
Compound class Antibody
International Nonproprietary Names Click here for help
INN number INN
11659 botensilimab
Synonyms Click here for help
AGEN-1181 | AGEN1181
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 1123
Other databases
GtoPdb PubChem SID 530846838
Search PubMed clinical trials botensilimab
Search PubMed titles botensilimab
Search PubMed titles/abstracts botensilimab